Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing.
Flanagan
P
P
Snape
T
T
D001688:Biological Products / Q000302:isolation & purification / Q000592:standards*; D001782:Blood Donors; D001803:Blood Transfusion / Q000592:standards*; D005591:Chemical Fractionation; D004739:England; D005062:European Union; D017408:Guidelines as Topic; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D006526:Hepatitis C / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D010949:Plasma / Q000821:virology*; D016133:Polymerase Chain Reaction / Q000379:methods*; D012367:RNA, Viral / Q000097:blood*; D012306:Risk; D012680:Sensitivity and Specificity; D014766:Viremia / Q000175:diagnosis* / Q000517:prevention & control
D001688:Biological Products; D012367:RNA, Viral